Previous Meetings

※Photographing or reproducing slides, videos of presentations, and abstracts is strictly prohibited without prior permission from the presenter and/or the GBCC.
*Uploaded presentation materials and recording videos of presentation are under the copyright transfer agreement.

Day 1, Apr 28 (Thu)

Day 2, Apr 29 (Fri)

Day 3, Apr 30 (Sat)

07:30-08:10

Breakfast Symposium 1
Venue:

Halla Hall

Getting Targeted Therapy Development Up-to-date in Breast Cancer
Joohyuk Sohn (Yonsei Cancer Center, Korea)Slide View Video View Abstract

08:30-09:30

Plenary Lecture 3
Venue:

Halla Hall

Maximizing Cosmetic and Oncologic Outcomes with Oncoplastic Techniques
Jean-Yves Petit (European Institute of Oncology, Italy)Video View Abstract

09:40-10:50

Symposium 3:

Additional Imaging Modality for the Management of Breast Cancer Patients
Venue:

Halla Hall

How to Use Magnetic Resonance Imaging Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Nariya Cho (Seoul National Univ. College of Medicine, Seoul National Univ. Hospital, Korea)Slide View Video View Abstract
Current Role and Challenge of PET-CT in Breast Cancer
Sung-Eun Kim (Korea Univ. Anam Hospital, Korea)Slide View Video View Abstract
PET/MR in Breast Cancer
Sang Moo Lim (Korea Institute of Radiological & Medical Sciences, Korea)Slide View Video View Abstract

Symposium 4:

Breast Cancer Survivorship in Precision Medicine Era
Venue:

Lotus Hall

Influence of Lifestyle Factors on Breast Cancer Prognosis
Xiao-Ou Shu (Vanderbilt Univ., U.S.A.)Slide View Video View Abstract
Evidence that Germline Genetic Factors Influence Survivorship from the Australian Breast Cancer Family Study
John Hopper (Univ. of Melbourne, Australia)Slide View Video View Abstract
Quality Adjusted Life Years Loss due to Breast Cancer in Korea
Min-Woo Jo (Univ. of Ulsan College of Medicine, Korea)Slide View Video View Abstract

11:00-12:10

Symposium 5:

Role of Cytotoxic Chemotherapy in the Era of Personalized Medicine
Venue:

Halla Hall

Nab-Paclitaxel in Breast Cancer: Clinical Development and Future Directions
Stefan Glück (Celgene Corporation, U.S.A.)Video View Abstract
Eribulin Mesylate in the Management of Metastatic Breast Cancer
Alison Jones (Leaders in Oncology Care, United Kingdom)Slide View Video View Abstract
Non-Anthracycline Adjuvant Chemotherapy
Yee Soo Chae (Kyungpook National Univ. Medical Center, Korea)Slide View Video View Abstract

Symposium 6:

Potential of Overcoming Resistance to HER2-targeted Therapies
Venue:

Lotus Hall

PIK3CA Mutations in HER2-positive Breast Cancer
Seock-Ah Im (Seoul National Univ. Hospital, Korea)Slide View Video View Abstract
Overcoming HER2 Targeted Therapy: Ongoing Challenge
Yoon Sim Yap (National Cancer Centre Singapore, Singapore)Slide View Video View Abstract
Precision Medicine Guided by Single-molecule Imaging
Tae-Young Yoon (Yonsei Univ., Korea)Video View Abstract

Survivorship Session:

Advanced Care and Research in Breast Cancer Survivorship
Venue:

Weolla Room

Communication and Unmet Needs of Patients/Families/Caregivers
Juhee Cho (Sungkyunkwan Univ. School of Medicine, Korea)Slide View Abstract
Patient Navigation Services for Breast Cancer Survivors
Jung-Won Lim (Kangnam Univ., Korea)Slide View Abstract
M-Health Application beyond Quality of Life for Breast Cancer Survivors
Jong Won Lee (ASAN Medical Center, Korea)Abstract

12:10-13:10

Luncheon Symposium 2
Venue:

Halla Hall

Rethinking Neoadjuvant Therapy: Neoadjuvant Therapy as a Platform for Drug Development in HER2 Positive Breast Cancer
Jee Hyun Kim (Seoul National Univ. Bundang Hospital, Korea)Slide View Video View Abstract

13:10-14:50

Nursing Session:

Current Issues for Management of Breast Cancer Treatment
Venue:

Weolla Room

Nursing Care in Endocrine Therapy
Jung A Do (Cheil General Hospital & Women's Healthcare Center, Korea)Slide View Abstract
Chemotherapy-related Cognitive Function in Patients with Breast Cancer
Jin-Hee Park (Ajou Univ. College of Nursing, Korea)Slide View Abstract
Chemotherapy Induced Peripheral Neuropathy Breast Cancer Patients
Mi Sook Han (Inha Univ. Hospital, Korea)Slide View Abstract
Nursing Care in Cardiotoxicity
Onam Ok (Samsung Medical Center, Korea)Slide View Abstract
Nursing Management for Patients with Advanced Breast Cancer Wound
Hyun Seo (Ewha Womans Univ. Mokdong Hospital, Korea)Slide View Abstract

13:30-14:30

Plenary Lecture 4
Venue:

Halla Hall

What Is the Next Goal of HER-2 Targeted Therapy
Hope Rugo (Univ. of California San Francisco Medical Center, U.S.A.)Slide View Video View Abstract

14:30-15:50

Panel Discussion 3:

What Is the Best in Breast Cancer Surgery?
Venue:

Lotus Hall

Surgery of the Primary Tumor in De Novo Metastatic Breast Cancer: To do or Not to do
Byung Ho Son (ASAN Medical Center, Univ. of Ulsan College of Medicine, Korea)Slide View Video View Abstract
Minimally Invasive, Maximal Outcomes in Breast Surgery
Eun Sook Lee (National Cancer Center, Korea)Slide View Video View Abstract
Cavity Shave Margins: Method and Impact on Practice
Anees Cagpar (Yale Univ. School of Medicine, U.S.A.)Slide View Video View Abstract

14:40-15:50

Symposium 7:

Challenging Treatment for TNBC
Venue:

Halla Hall

Molecular Heterogeneity of TNBC and Methods of Classification
Joon Jeong (Gangnam Severance Hospital, Yonsei Univ., Korea)Video View Abstract
The Future of Personalized Therapy in Triple-negative Breast Cancer
Masakazu Toi (Kyoto Univ. Hospital, Japan)Slide View Video View Abstract
New Treatment Directions for Triple-negative Breast Cancer
Naoto Ueno (The Univ. of Texas, MD Anderson Cancer Center, U.S.A.)Slide View Video View Abstract

16:00-17:20

ABRCA & HBOC
Venue:

Lotus Hall

Precision Medicine for Cancer: the BRCA1/2 Paradigm
Timothy Rebbeck (Harvard TH Chan School of Public Health and Dana Farber Cancer Institute, U.S.A.)Slide View Video View Abstract
Management of Hereditary Breast Cancer: Advances and Controversies
Ava Kwong (The Univ. of Hong Kong, Hong Kong)Slide View Video View Abstract
Gene-panel Sequencing in the Context of the Prediction of Breast Cancer Risk in Asia
Soo-Hwang Teo (Cancer Research Malaysia, Malaysia)Video View Abstract

ABC Networking Business Meeting
Venue:

Weolla Room

Presentation about ABCN Collaborative Group
Young-Jin Suh (The Catholic Univ. of Korea, St. Vincent's Hospital, Korea)
Presentation about ABCN Mentorship
Hyeona Kim (Korea Cancer Center Hospital, Korea)
Wisdom Sharing for Asian Collaboration
Louis Wing-Cheong Chow (Macau Univ. of Science and Technology, Macau)

16:10-17:20

Panel Discussion 4:

Challenging Treatments for CNS Metastasis from Breast Cancer
Venue:

Halla Hall

Current Challenges in Treating Breast Cancer Patients with Metastasis to Brain, Sneak Peak of Upcoming Biology
Bora Lim (The Univ. of Texas, MD Anderson Cancer Center, U.S.A.)Slide View Video View Abstract
Current Issues in the Management of Brain Metastases from Breast Cancer
Kyubo Kim (Ewha Womans Univ. School of Medicine, Korea)Slide View Video View Abstract

17:30-18:30

Dinner Symposium
Venue:

Halla Hall

Determining the Optimal Adjuvant Chemotherapy for Lower or Intermediate Risk of Breast Cancer - Who Should Receive Adjuvant Chemotherapy?
Kyoung Eun Lee (Ewha Womans Univ. Mokdong Hospital, Korea)Slide View Video View Abstract

KEEP ME UPDATED

Sign up for GBCC Newsletter

Global Breast Cancer Conference Secretariat